Enliven Therapeutics, Inc. (ELVN): 10-Q filed Nov 5, 2026

Form type

10-Q

Filing date

Nov 5, 2026

Accession number

0001193125-26-449870

Filer

Enliven Therapeutics, Inc. (CIK 1672619)